Hiroshi Mitoma Selected Research

Infections

11/2023	Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.
8/2020	Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Mitoma Research Topics

Disease

33	Cerebellar Ataxia (Dysmetria) 11/2023 - 04/2003
19	Ataxia (Dyssynergia) 04/2024 - 01/2009
9	Paraneoplastic Cerebellar Degeneration 04/2024 - 01/2015
6	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 04/2024 - 01/2019
6	Neoplasms (Cancer) 11/2023 - 10/2014
5	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2017
4	Miller Fisher Syndrome (Fisher Syndrome) 04/2024 - 04/2016
4	Cerebellar Diseases (Cerebellar Syndrome) 07/2023 - 01/2018
3	Multiple Sclerosis 04/2024 - 08/2018
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 01/2015
3	Atrophy 01/2016 - 01/2009
3	Multiple System Atrophy 01/2016 - 01/2009
2	Behcet Syndrome (Behcet's Syndrome) 04/2024 - 11/2023
2	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 04/2024 - 11/2023
2	Infections 11/2023 - 08/2020
2	Disease Progression 12/2019 - 01/2017
2	Hashimoto's encephalitis 04/2016 - 01/2015
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2016 - 10/2014
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2015 - 05/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 02/2007
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Neuroinflammatory Diseases 01/2021
1	Thiamine Deficiency 01/2021
1	Fetal Alcohol Spectrum Disorders 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 08/2020
1	Cytokine Release Syndrome 08/2020
1	Leukocytosis (Pleocytosis) 08/2020
1	Movement Disorders (Movement Disorder) 08/2019
1	Brain Diseases (Brain Disorder) 12/2018
1	Wounds and Injuries (Trauma) 08/2018
1	Stroke (Strokes) 08/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2016
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Medically Unexplained Symptoms 05/2009
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2009

Drug/Important Bio-Agent (IBA)

13	Glutens (Glutelin)IBA 04/2024 - 01/2009
10	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 04/2024 - 04/2003
10	AutoantibodiesIBA 07/2020 - 04/2003
9	AntibodiesIBA 02/2023 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 02/2023 - 07/2020
5	GliadinIBA 01/2016 - 01/2009
3	Ion Channels (Ion Channel)IBA 08/2022 - 07/2020
3	EpitopesIBA 01/2017 - 01/2015
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2015 - 01/2009
2	CollagenIBA 04/2024 - 11/2023
2	Biomarkers (Surrogate Marker)IBA 06/2023 - 08/2020
2	AntigensIBA 08/2022 - 01/2019
2	metabotropic glutamate receptor type 1IBA 02/2022 - 01/2021
2	Glutamate Receptors (Glutamate Receptor)IBA 02/2022 - 01/2021
2	Carboxy-LyasesIBA 05/2021 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2020 - 01/2015
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2016 - 10/2014
1	Glial Fibrillary Acidic ProteinIBA 04/2024
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Oligoclonal BandsIBA 08/2020
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 07/2020
1	istradefyllineIBA 08/2019
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 08/2019
1	AminopyridinesIBA 01/2019
1	AntioxidantsIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2018
1	Selegiline (E250)FDA LinkGeneric 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Peptides (Polypeptides)IBA 10/2014
1	gamma-Aminobutyric Acid (GABA)IBA 05/2013
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2009
1	Immunoglobulin A (IgA)IBA 01/2009
1	SS-A antibodiesIBA 01/2009
1	Immunoglobulin G (IgG)IBA 02/2007

Therapy/Procedure

12	Therapeutics 11/2023 - 01/2009
5	Immunotherapy 01/2017 - 01/2009
3	Wearable Electronic Devices 04/2020 - 01/2017
2	Activities of Daily Living (ADL) 01/2022 - 09/2016
2	Gluten-Free Diet 01/2019 - 10/2014
1	Secondary Prevention 08/2022
1	Transplantation 06/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2019
1	Oral Administration 10/2014